Hims & Hers CMO settles 26K RSUs, 10K withheld

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) reported that Chief Medical Officer Patrick Harrison Carroll exercised and settled several Restricted Stock Unit (RSU) awards into a total of 26,187 shares of Class A Common Stock on 2026-08-14 at a conversion price of $0.00 per share. The company withheld 10,201 shares at $28.15 per share to cover tax withholding obligations related to these vestings. Footnotes state that one RSU grant was issued under the issuer’s Director Compensation Policy in lieu of $7,912 of cash fees at a grant price of $30.40, and that other RSU blocks vest over four years based on continued service.

Insider Trade Summary

26,187 shares exercised/converted

Exercise 8 txns

Insider Carroll Patrick Harrison

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F3	260	$0.00	$0.00
Exercise	Restricted Stock Unit F1, F4	8,149	$0.00	$0.00
Exercise	Restricted Stock Unit F1, F5	4,839	$0.00	$0.00
Exercise	Restricted Stock Unit F1, F6	3,533	$0.00	$0.00
Exercise	Restricted Stock Unit F1, F7	9,406	$0.00	$0.00
Exercise	Class A Common Stock F1	260	--	--
Exercise	Class A Common Stock F1	25,927	--	--
Tax Withholding	Class A Common Stock F2	10,201	$28.15	$287K

Holdings After Transaction: Restricted Stock Unit — 204,196 contracts (Direct); Class A Common Stock — 197,847 shares (Direct)

Footnotes (7)

1. F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
3. F3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $7,912 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
4. F4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the Company's quarterly vesting dates occurring thereafter.
5. F5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
6. F6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
7. F7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Key Figures

RSUs converted: 26,187 shares Shares withheld for taxes: 10,201 shares Tax withholding price: $28.15 per share +3 more

6 metrics

RSUs converted 26,187 shares Total underlying Class A Common Stock from RSUs exercised on 2026-08-14

Shares withheld for taxes 10,201 shares Class A shares withheld to cover tax obligations at vesting

Tax withholding price $28.15 per share Price used for shares withheld to satisfy tax withholding obligations

Foregone cash fees $7,912 Director retainer fee replaced by an RSU grant for Q2 2026

RSU grant price $30.40 Grant price used to calculate RSUs issued in lieu of cash fees

RSU vesting period 4 years Service-based vesting schedules for several RSU grants

Key Terms

Restricted Stock Unit, service-based vesting requirement, Director Compensation Policy, quarterly vesting dates

4 terms

Restricted Stock Unit financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

service-based vesting requirement financial

"The RSUs are subject to a service-based vesting requirement, which shall be satisfied"

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy"

quarterly vesting dates financial

"vesting in substantially equal quarterly installments on the Company's quarterly vesting dates"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity activity did HIMS report for Patrick Harrison Carroll on this Form 4?

Hims & Hers Health, Inc. (HIMS) reported that Patrick Harrison Carroll settled multiple RSU awards into 26,187 shares of Class A Common Stock on 2026-08-14. These transactions reflect equity compensation vesting rather than open-market purchases or sales.

How many HIMS shares were withheld for taxes in this Form 4 transaction?

The issuer withheld 10,201 shares of Hims & Hers Health, Inc. Class A Common Stock at $28.15 per share to satisfy tax withholding obligations. This withholding occurred in connection with the vesting and settlement of RSUs held by Patrick Harrison Carroll.

What is the relationship between the RSUs and HIMS Class A Common Stock?

Each RSU reported for Hims & Hers Health, Inc. represents a contingent right to receive one share of Class A Common Stock. Upon vesting and settlement, the RSUs were converted into an equal number of Class A shares credited to the reporting person.

Were any of Patrick Harrison Carroll’s HIMS RSUs related to director compensation?

One RSU block is described as granted under Hims & Hers Health, Inc.’s Director Compensation Policy, in lieu of a $7,912 cash director retainer for the second quarter of 2026. The number of RSUs was determined using a $30.40 grant price.

What are the vesting terms of the RSUs reported by HIMS on this Form 4?

The RSUs reported for Hims & Hers Health, Inc. are subject to service-based vesting over four-year schedules. Depending on the grant, vesting occurs on specific initial dates and then in substantially equal quarterly installments on company quarterly vesting dates.

Did Patrick Harrison Carroll buy or sell HIMS shares on the open market?

The Form 4 shows no open-market purchases or sales of Hims & Hers Health, Inc. shares. Reported activity consists of RSU exercises/conversions into Class A Common Stock and shares withheld by the issuer to pay tax obligations on those vestings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 05:05 PM EDT Accepted by SEC EDGAR 08/18/2026 - 05:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carroll Patrick Harrison

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/14/2026		M		260	A	(1)	182,121	D
Class A Common Stock	08/14/2026		M		25,927	A	(1)	208,048	D
Class A Common Stock	08/14/2026		F		10,201(2)	D	$28.15	197,847	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/14/2026		M			260	(3)	(3)	Class A Common Stock	260	$0	0	D
Restricted Stock Unit	(1)	08/14/2026		M			8,149	(4)	(4)	Class A Common Stock	8,149	$0	8,149	D
Restricted Stock Unit	(1)	08/14/2026		M			4,839	(5)	(5)	Class A Common Stock	4,839	$0	29,038	D
Restricted Stock Unit	(1)	08/14/2026		M			3,533	(6)	(6)	Class A Common Stock	3,533	$0	35,331	D
Restricted Stock Unit	(1)	08/14/2026		M			9,406	(7)	(7)	Class A Common Stock	9,406	$0	131,678	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $7,912 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the Company's quarterly vesting dates occurring thereafter.

5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.

6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.

7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)